AngioDynamics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
AngioDynamics, Inc. (ANGO) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $11.22 million as of 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-07-14
- 2026-05-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $11.22M.
- 2026-02-28: Finite-Lived Intangible Asset, Expected Amortization, Year One $10.69M.
- 2025-11-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $10.53M.
- 2025-08-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $10.42M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-05-31 | $11.22M 10-K · filed 2026-07-14 |
| 2026-02-28 | $10.69M 10-Q · filed 2026-04-02 |
| 2025-11-30 | $10.53M 10-Q · filed 2026-01-06 |
| 2025-08-31 | $10.42M 10-Q · filed 2025-10-02 |
| 2025-05-31 | $10.30M 10-K · filed 2025-07-18 |
| 2025-02-28 | $10.22M 10-Q · filed 2025-04-02 |
| 2024-11-30 | $10.18M 10-Q · filed 2025-01-08 |
| 2024-08-31 | $10.18M 10-Q · filed 2024-10-03 |
| 2024-05-31 | $10.27M 10-K · filed 2024-07-25 |
| 2024-02-29 | $10.42M 10-Q · filed 2024-04-09 |
| 2023-11-30 | $14.38M 10-Q · filed 2024-01-08 |
| 2023-08-31 | $14.30M 10-Q · filed 2023-10-05 |
| 2023-05-31 | $14.40M 10-K · filed 2023-08-03 |
| 2023-02-28 | $16.41M 10-Q · filed 2023-03-31 |
| 2022-11-30 | $16.68M 10-Q · filed 2023-01-06 |
| 2022-08-31 | $16.78M 10-Q · filed 2022-10-11 |
| 2022-05-31 | $18.88M 10-K · filed 2022-07-22 |
| 2022-02-28 | $19.03M 10-Q · filed 2022-04-07 |
| 2021-11-30 | $19.11M 10-Q · filed 2022-01-07 |
| 2021-08-31 | $19.03M 10-Q · filed 2021-09-30 |
| 2021-05-31 | $15.16M 10-K · filed 2021-07-27 |
| 2021-02-28 | $17.01M 10-Q · filed 2021-03-31 |
| 2020-11-30 | $17.04M 10-Q · filed 2021-01-08 |
| 2020-08-31 | $17.59M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $18.60M 10-K · filed 2020-08-10 |
| 2019-05-31 | $15.25M 10-K · filed 2019-07-25 |
| 2018-05-31 | $16.55M 10-K · filed 2018-07-23 |
| 2017-05-31 | $16.50M 10-K · filed 2017-08-04 |
| 2016-05-31 | $19.05M 10-K · filed 2016-08-01 |
| 2015-05-31 | $18.45M 10-K · filed 2015-08-10 |
| 2014-05-31 | $15.69M 10-K · filed 2015-01-12 |
| 2013-05-31 | $15.20M 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |